GET DAILY SIGNALSHerbalife (HLF) Posts Fifth Consecutive Quarter of Sales Growth in Q3
Key Takeaways
- Herbalife reported third-quarter 2026 net sales of $1,350.2 million, up 6.0% year over year and its fifth consecutive quarter of top-line growth.
- Adjusted diluted earnings per share (EPS) came in at $0.64, above the consensus estimate of $0.62 and up $0.14 from the prior-year quarter.
- Adjusted EBITDA reached $182 million, exceeding the company's guidance range of $160 million to $180 million.
- Worldwide volume rose 8.6% year over year, with India driving outsized growth as net sales there climbed roughly 39% on a reported basis.
- Year-to-date operating cash flow reached $298 million, up about 27% versus the first nine months of 2025.
Why These Results Stand Out
Herbalife's third-quarter report provides a useful checkpoint on whether the company's multi-year turnaround is gaining sustained traction. After navigating uneven growth and restructuring efforts, the business has now delivered five straight quarters of year-over-year sales expansion. From what I see, investors are focused on whether this recovery is spreading across regions or still concentrated in key markets like India. The results also shed light on distributor trends, pricing dynamics, and cash generation, factors that influence how the market values the stock given its debt levels.
Quarterly Performance Breakdown
For the third quarter ended September 30, 2026, HLF reported net sales of $1,350.2 million, up 6.0% from $1,273.7 million a year earlier and above the consensus revenue estimate of roughly $1.32 billion. Adjusted diluted EPS was $0.64, beating the consensus estimate of $0.62. On a GAAP basis, diluted EPS was $0.55, up from $0.42 in the prior-year period.
Net income attributable to Herbalife was $58.8 million, up 36% year over year. Adjusted EBITDA rose to $182 million, above the company's guidance range of $160 million to $180 million, with adjusted EBITDA margin expanding 70 basis points to 13.5%. Gross profit margin was 77.3%, down 40 basis points year over year, reflecting country mix and sourcing costs partly offset by pricing benefits. Worldwide volume increased 8.6%. I also checked this using Tickeron's AI Screener to see how the stock compares to others in the industry.
Market Response and Sentiment
Shares of HLF moved higher following the release, with investors responding positively to an earnings beat and revenue that exceeded consensus. The market's reaction appeared driven by the company's fifth consecutive quarter of growth, above-guidance adjusted EBITDA, and strengthening cash flow. India's outsized contribution was a focal point, with some attention on whether the country's growth is sustainable as the company laps a favorable comparison from the prior year. Foreign-exchange headwinds remained a factor but did not derail the broadly upbeat tone.
What to Watch Going Forward
Looking ahead, investors will be watching whether Herbalife can sustain its growth streak as it laps a strong prior-year comparison in India. The company has signaled that it expects continued growth in that market even after lapping the change in India's GST that boosted prior-period results.
Margin trends will be another key focus. While adjusted EBITDA margin expanded year over year, gross margin declined modestly on country mix and self-manufacturing costs. The balance between pricing benefits and these cost pressures will help determine whether profitability gains continue.
Cash generation and debt reduction also remain central themes. With year-to-date operating cash flow up about 27%, investors will monitor leverage progress and any capital-allocation updates. Finally, strategic initiatives, including the expansion of the Bioniq premium wellness brand and broader distributor ecosystem investments, may provide additional catalysts in the quarters ahead.
Using AI Tools in My Research
When analyzing earnings-driven moves like this one from HLF, I often turn to Tickeron's AI-powered tools to scan for similar patterns across the sector. The AI Screener helps surface comparable setups and momentum signals that complement traditional fundamental review, giving a clearer view of potential trade opportunities without replacing core analysis.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
HLF's RSI Indicator leaves overbought zone
The 10-day RSI Indicator for HLF moved out of overbought territory on October 19, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 instances where the indicator moved out of the overbought zone. In 27 of the 29 cases the stock moved lower in the days that followed. This puts the odds of a move down at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 26, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HLF as a result. In 69 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 82%.
The Moving Average Convergence Divergence Histogram (MACD) for HLF turned negative on October 23, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 35 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 78%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HLF declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
HLF broke above its upper Bollinger Band on October 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
HLF moved above its 50-day moving average on October 01, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for HLF crossed bullishly above the 50-day moving average on October 01, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 64%.
Following a +2.89% 3-day Advance, the price is estimated to grow further. Considering data from situations where HLF advanced for three days, in 201 of 276 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.
The Aroon Indicator entered an Uptrend today. In 136 of 187 cases where HLF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 73%.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 2 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 6 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 36 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-2.882) is normal, around the industry mean (7.678). P/E Ratio (8.259) is within average values for comparable stocks, (6.461). Projected Growth (PEG Ratio) (0.120) is also within normal values, averaging (8.458). Dividend Yield (0.046) settles around the average of (0.048) among similar stocks. P/S Ratio (0.241) is also within normal values, averaging (5.003).
The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. HLF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HLF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a manufacturer of weight management and personal care products
Industry FoodMajorDiversified
Advertisement